半岛·体育(中国)官方网站-登陆入口

Investor Relations

Consun Pharma Interim results review and NDR Takeaway

date：2019-01-14  Views：9396 times

Prev：Consun Pharma (1681 HK) Unjustifiably low valuation despite solid fundamentals

Next：Consun Pharma (1681 HK) 1H18 results in line

400-930-1681

总机：（86）20-82016888

service@chinaconsun.com

71 Dongpeng Avenue, Huangpu District, Guangzhou

  • Consun

  • Health Station

  • Micro mall

工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号Design: uweb